Probiotics vs Prebiotics: Most People Are Taking the Wrong Thing for the Wrong Reason

The gut microbiome has become the hottest topic in nutritional science — and consequently one of the most commercially exploited. UK sales of probiotic supplements exceed £200 million annually, yet the majority of products on shelves are formulated with strains at doses that the evidence does not support for the conditions they implicitly claim to treat.

Understanding probiotics and prebiotics correctly means understanding that specificity is everything. A blanket "probiotic" no more "supports gut health" in a meaningful sense than a blanket "antibiotic" treats a specific infection.

---

The Microbiome: Why It Matters

The human gut hosts approximately 38 trillion microbial cells — roughly equal to the number of human cells in the body. This community of bacteria, archaea, fungi, and viruses performs functions that are genuinely critical to health:

- Digestion of dietary fibre — producing short-chain fatty acids (SCFAs: butyrate, propionate, acetate) that fuel the gut lining and regulate inflammation - Immune regulation — 70% of immune tissue is in the gut; gut bacteria train and modulate the immune system - Neurotransmitter production — approximately 95% of serotonin is produced in the gut, influenced by gut bacteria - Bile acid modification — affecting cholesterol metabolism and hormonal recycling - Vitamin K2 and certain B vitamins — synthesised by gut bacteria - Barrier function — maintaining the tight junctions of the intestinal epithelium that prevent "leaky gut" - Pathogen competition — colonisation resistance against pathogens like C. difficile

Disruption of the microbiome (dysbiosis) is associated with — though not always causally proven for — IBS, inflammatory bowel disease, obesity, type 2 diabetes, depression, anxiety, autoimmune conditions, and allergy.

---

Probiotics: The Strain Specificity Principle

A probiotic is a live microorganism that, when administered in adequate amounts, confers a health benefit on the host. (WHO/FAO definition)

The three words that matter: specific organism, adequate amount, specific benefit.

Evidence for probiotics is strain-specific — what is proven for one strain cannot be extrapolated to another, even within the same species. Lactobacillus rhamnosus GG and Lactobacillus rhamnosus Lcr35 are different strains with different evidence bases.

The implication: A product labelled "Lactobacillus acidophilus" without the strain designation (e.g., La-5, NCFM) cannot be evaluated against clinical evidence.

---

The CFU Myth

"50 billion CFU!" shout the labels of premium UK probiotics. Colony-forming units measure the number of live bacteria at time of manufacture. What they do not tell you:

- What percentage survive manufacturing - What percentage survive stomach acid on the way to the intestine - What percentage implant in the gut versus transit and are excreted - Whether they survive until the use-by date (shelf-stable products often undergo substantial die-off)

A product with 50 billion CFU of a fragile strain with poor acid resistance may deliver fewer viable bacteria to the colon than one with 5 billion CFU of an acid-resistant, enteric-coated strain.

Survivability is more important than headline CFU count.

How to assess survivability: - Enteric coating or delayed-release capsules protect bacteria through stomach acid - Refrigerated products may preserve viability better (though some shelf-stable products use viable freeze-drying) - Research-backed strains with published stability data - Spore-forming bacteria (Bacillus coagulans, Bacillus subtilis) are inherently acid-resistant without special formulation

---

Specific Strains for Specific Conditions

This is the core of evidence-based probiotic use:

Antibiotic-Associated Diarrhoea and C. Difficile Prevention

Strain: Lactobacillus rhamnosus GG (Culturelle brand) and Saccharomyces boulardii (yeast, not bacteria) - Cochrane review: LGG and S. boulardii each reduce antibiotic-associated diarrhoea risk by approximately 50% - S. boulardii specifically reduces C. difficile infection risk in high-risk patients - Start at the same time as antibiotics; take 2+ hours apart from antibiotic dose - Continue for 2 weeks after antibiotic course ends

Traveller's Diarrhoea

Strain: Lactobacillus rhamnosus GG or Saccharomyces boulardii - Both have evidence for reducing traveller's diarrhoea risk and duration - Start 2 days before travel, continue throughout

IBS (Mixed or Diarrhoea-Predominant)

Strains with evidence: - Bifidobacterium infantis 35624 (Alflorex) — best single-strain IBS evidence, multiple RCTs showing reduced IBS symptom score - Lactobacillus plantarum 299v — improves bloating and flatulence in IBS - Multi-strain products (VSL#3 in severe IBS) — some evidence for diarrhoea-predominant IBS - Duration: minimum 8 weeks before evaluating response

IBS-constipation: Less evidence, but Bifidobacterium lactis BB-12 has some RCT support

Vaginal Health

Strains: Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 (Fem-Dophilus brand) - RCTs show oral supplementation with these strains colonises the vaginal tract and significantly reduces bacterial vaginosis recurrence and candidal vaginitis - The strains reach the vagina via intestinal-vaginal migration — oral administration, not topical, is the evidence-based route

Depression and Anxiety (Psychobiotics)

An emerging and exciting field: - Lactobacillus rhamnosus (JB-1) reduced anxiety-like behaviour in animal models - Lactobacillus helveticus R0052 + Bifidobacterium longum R0175 reduced anxiety scores in humans (Messaoudi et al., 2011) - Bifidobacterium longum 1714 improved stress response in healthy volunteers Human evidence is promising but small-scale. The gut-brain axis mechanism (vagus nerve, serotonin production) is compelling.

Infant Colic

Strain: Lactobacillus reuteri DSM 17938 (BioGaia) - Multiple RCTs in breastfed infants show significant reduction in crying time - Effect is smaller in formula-fed infants - This is one of the strongest probiotic evidence bases in paediatrics

---

Prebiotics: Feeding the Good Bacteria

A prebiotic is a substrate that is selectively utilised by host microorganisms conferring a health benefit. In practical terms: food for the good bacteria already in your gut.

The key types:

Inulin and FOS (Fructooligosaccharides)

Found in: chicory root, onions, garlic, leeks, asparagus, artichokes, bananas - Selectively feed Bifidobacterium species - Increase SCFA production (especially butyrate from inulin fermentation) - Can cause significant gas and bloating at higher doses — start low and increase slowly - Inulin-type fructans are well-studied and included in the EFSA-approved health claims register

GOS (Galactooligosaccharides)

Found in: legumes, breast milk - Bifidogenic (promotes Bifidobacterium growth) - Better tolerated than inulin in many people - Used in infant formula as a prebiotic

Resistant Starch

Found in: cooled cooked potatoes, cooled cooked rice, green bananas, oats, legumes - Fermented to butyrate by the gut microbiome — the primary fuel for colonocytes (gut lining cells) - High butyrate production is associated with reduced colorectal cancer risk - RS content increases when cooked starches are cooled (retrograde resistant starch)

Beta-Glucan

Found in: oats, barley, mushrooms - Prebiotic effects plus direct immune-modulating activity - The EFSA has approved a health claim for oat beta-glucan reducing LDL cholesterol

---

Postbiotics: The Emerging Category

Postbiotics are metabolic by-products of probiotic bacteria — butyrate, propionate, acetate, bacteriocins, short-chain fatty acids, peptides, and cell wall fragments. They may provide benefits without requiring live bacteria to survive to the gut.

This is an emerging category with significant commercial interest. The rationale is sound — many of the beneficial effects of probiotics may be mediated by their metabolic products rather than the live bacteria themselves. Watch this space.

---

Synbiotics

Products combining probiotics and prebiotics (designed to improve probiotic survival and activity) are called synbiotics. The theoretical advantage is sound but clinical evidence of superiority over either component alone is limited.

---

Storage Matters More Than Most Realise

- Refrigerated probiotics: Most Lactobacillus and Bifidobacterium strains die rapidly at room temperature. A product that was refrigerated in the pharmacy but stored on a warm shelf at home for 3 months may contain a fraction of the stated CFU. - Shelf-stable claims: Only valid when the formulation has been tested for stability under the stated storage conditions. Legitimate shelf-stable products use freeze-dried bacteria in moisture-barrier packaging. - Buy from stores with high product turnover. Old stock sitting in hot warehouses produces inferior products.

---

Antibiotic Recovery Protocol

Post-antibiotic microbiome disruption is one of the most common and legitimate uses for probiotics:

1. During antibiotics: Saccharomyces boulardii 500mg + L. rhamnosus GG, taken 2 hours away from each antibiotic dose 2. Post-antibiotics (2–4 weeks): Broad-spectrum multi-strain probiotic (Lactobacillus + Bifidobacterium species) daily 3. Diet: High-fibre, diverse plant foods to support microbiome recovery. Fermented foods (yoghurt, kefir, sauerkraut) provide a diversity of live cultures. 4. Prebiotic support: Inulin or GOS supplementation alongside probiotics accelerates microbiome recovery

Research (Suez et al., Cell, 2018) controversially showed that standard probiotic use after antibiotics may actually slow microbiome reconstitution vs spontaneous recovery. However, this was a single study using a specific combination; S. boulardii and L. rhamnosus GG for antibiotic-diarrhoea prevention retain strong evidence.

---

The Bottom Line

The probiotic market is filled with products that are dosed below therapeutic levels, use strains with no clinical evidence, and claim general "gut health" benefits without specificity. The evidence is real but narrow: specific strains, at specific doses, for specific conditions, delivered with survivability intact.

Know what you're treating. Match the strain to the evidence. Look for products naming specific strain codes (GG, RC-14, 35624) rather than just species. And remember that for most people, diverse plant food consumption and a high-fibre diet will do more for microbiome health than any supplement — probiotics are tools for specific clinical situations, not a substitute for a good diet.